Yazar "Gokmen, E." seçeneğine göre listele
Listeleniyor 1 - 10 / 10
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Cost effectiveness of Oncotype DX test in patients with early-stage breast cancer in a middle-income country, Turkey: results of a prospective multicenter study(Churchill Livingstone, 2017) Ozmen, V.; Gokmen, E.; Atasoy, A.; Ozdogan, M.; Guler, N.; Uras, C.; Ok, E.; Demircan, O.; Isikdogan, A.; Saip, P.Öğe Expression of cyclin D1 and its relation with ER, PgR, C-erbB2, Ki-67, and p53 in breast cancer.(Amer Soc Clinical Oncology, 2010) Haydaroglu, A.; Demirci, S.; Demir, D.; Aydin, B.; Bolukbasi, Y.; Zekioglu, O.; Yeniay, L.; Ozdemir, N.; Gokmen, E.; Ylmaz, R.Öğe The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients(Amer Soc Clinical Oncology, 2011) Basaran, G.; Saglam, S.; Tansan, S.; Demirel, M.; Gokmen, E.; Aktan, S.; Goker, E.; Kaban, K. K.; Saip, P.; Demir, G.; Bavbek, S. E.; Mandel, N. M.; Tecimer, C.; Turhal, N. S.; Garipoglu, M.Öğe Investigation of the cell death in pancreatic cancer after silencing of elongation factor 2 alpha by siRNA(Mary Ann Liebert, Inc, 2016) Ergin, K.; Erdogan, A. M.; Gokmen, E.; Armagan, G. D.; Olgun, H. N.; Aktas, S. G.; Sehne, M.; Suzek, T.; Ozpolat, B.Öğe MIPI-TURK - Multicentric Ipilimumab Experience in Turkish Patients With Metastatic Melanoma(Elsevier Sci Ltd, 2011) Sevinc, A.; Ozdogan, M.; Buyukberber, S.; Aydin, F.; Mandel, N. M.; Demir, O. G.; Gokmen, E.; Arpaci, F.; Paydas, S.; Celik, I.Öğe Multicentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 years(Wiley-Blackwell, 2013) Sevinc, A.; Turna, H.; Ozdogan, M.; Buyukberber, S.; Demir, G.; Gokmen, E.; Mandel, N. M.; Paydas, S.; Akbulut, H.; Celik, I.Öğe Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer: An observational study of the Turkish Oncology Group.(Amer Soc Clinical Oncology, 2011) Icli, F.; Altundag, K.; Coskun, U.; Paydas, S.; Basaran, G.; Saip, P.; Dogu, G. G.; Eralp, Y.; Uslu, R.; Sevinc, A.; Onur, H.; Mandel, N. M.; Sezgin, C.; Altinbas, M.; Guler, N.; Isikdogan, A.; Gokmen, E.; Uygun, K.; Ustuner, Z.; Yaren, A.Öğe Phase III KEYNOTE-355 study of pembrolizumab (pembro) vs placebo (pbo) plus chemotherapy (chemo) for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC): Results for patients (Pts) enrolled in Asia(Elsevier, 2020) Yusof, M. Md; Cescon, D. W.; Rugo, H. S.; Im, S-A.; Gallardo, C.; Lipatov, O.; Gokmen, E.[No Abstract Available]Öğe THE PREDICTIVE AND PROGNOSTIC ROLE OF O6-METHYLGUANINE- DNA METHYLTRANSFERASE (MGMT) AND TISSUE TRANSGLUTAMINASE-2 (TGASE-2) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS TREATED WITH SUNITINIB(Oxford Univ Press, 2012) Tunali, D.; Sarsik, B.; Durusoy, R.; Sen, S.; Gokmen, E.Öğe A preliminary study on O6-methylguanine-DNA methyltransferase and Type 2 transglutaminase expression profile of renal cell carcinomas(Springer, 2012) Sarsik, B.; Pehlivanoglu, B.; Tunali, D.; Simsir, A.; Gokmen, E.; Sen, S.
